Prognostic value of transforming growth factor beta 1 [TGF-β1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma

References

• Bierie B, Moses HL. (2006). Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6:506–520.
   PubMed Web of Science ®Google Scholar
• Bundgaard T, Rossen K, Henriksen SD, Charabi S, Søgaard H, Grau C. (2002). Histopathologic parameters in the evaluation of T1 squamous cell carcinomas of the oral cavity. Head Neck 24:656–660.
   Google Scholar
• Chen Y, Zhang W, Geng N, Tian K, Jack Windsor L. (2008). MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus. Head Neck 30:1237–1245.
   PubMed Web of Science ®Google Scholar
• Cooper CR, Chay CH, Gendernalik JD, Lee H-L, Bhatia J, Taichman RS, McCauley LK, Keller ET, Pienta KJ. (2003). Stromal factors involved in prostate carcinoma metastasis to bone. Cancer 97:739–747.
   PubMed Web of Science ®Google Scholar
• Cortesina G, Martone T. (2006). Molecular metastases markers in head and neck squamous cell carcinoma: review of the literature. Acta Otorhinolaryngol Ital 26:317–325.
   PubMedGoogle Scholar
• Dai T, Song Y, Ma H, Feng H. (2007). Studies on the expression of MMP-9 and significance of a macrophage assay in oral squamous cell carcinoma. Chin J Clin Oncol 4:333–337.
   Google Scholar
• Dranoff G. (2004). Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11–22.
   PubMed Web of Science ®Google Scholar
• Görögh T, Beier UH, Bäumken J, Meyer JE, Hoffmann M, Gottschlich S, Maune S. (2006). Metalloproteinases and their inhibitors: influence on tumour invasiveness and metastasis formation in head and neck squamous cell carcinomas. Head Neck 28:31–39.
   Google Scholar
• Johansson N, Airola K, Grénman R, Kariniemi AL, Saarialho-Kere U, Kähäri VM. (1997). Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 151:499–508.
   PubMed Web of Science ®Google Scholar
• Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S, Harabuchi Y. (2004). Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumour metastases and prognosis. Clin Cancer Res 10:634–640.
   PubMed Web of Science ®Google Scholar
• Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H, Shirasuna K. (1999). Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumour invasion and metastasis. Head Neck 21:627–638.
   PubMed Web of Science ®Google Scholar
• Lewis MP, Lygoe KA, Nystrom ML, Anderson WP, Speight PM, Marshall JF, Thomas GJ. (2004). Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 90:822–832.
   PubMed Web of Science ®Google Scholar
• Logullo AF, Nonogaki S, Miguel RE, Kowalski LP, Nishimoto IN, Pasini FS, Federico MHH, Brentani RR, Brentani MM. (2003). Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis. J Oral Pathol Med 32:139–145.
   PubMed Web of Science ®Google Scholar
• Nagel H, Laskawi R, Wahlers A, Hemmerlein B. (2004). Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland. Histopathology 44:222–231.
   PubMed Web of Science ®Google Scholar
• O-Charoenrat P, Rhys-Evans PH, Eccles SA. (2001). Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127:813–820.
   PubMedGoogle Scholar
• Overall CM, Wrana JL, Sodek J. (1991). Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 266:14064–14071.
   PubMed Web of Science ®Google Scholar
• Pasini FS, Brentani MM, Kowalski LP, Federico MH. (2001). Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa. Head Neck 23:725–732.
   PubMed Web of Science ®Google Scholar
• Patel BP, Shah PM, Rawal UM, Desai AA, Shah SV, Rawal RM, Patel PS. (2005). Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 90:81–88.
   PubMed Web of Science ®Google Scholar
• Patel B, Shah S, Shukla S, Shah P, Patel P. (2007). Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck 29:564–572.
   PubMed Web of Science ®Google Scholar
• Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T. (2004). Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis. Clin Cancer Res 10:3110–3116.
   PubMed Web of Science ®Google Scholar
• Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H. (1991). Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 266:11436–11441.
   PubMed Web of Science ®Google Scholar
• Sinpitaksakul SN, Pimkhaokham A, Sanchavanakit N, Pavasant P. (2008). TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway. Biochem Biophys Res Commun 371:713–718.
   PubMed Web of Science ®Google Scholar
• Takiuchi H, Tada T, Li XF, Ogata M, Ikeda T, Fujimoto S, Fujiwara H, Hamaoka T. (1992). Particular types of tumour cells have the capacity to convert transforming growth factor beta from a latent to an active form. Cancer Res 52:5641–5646.
   PubMed Web of Science ®Google Scholar
• Tian M, Schiemann WP. (2009). The TGF-β Paradox in Human Cancer: An Update. Future Oncol (London, England) 5:259–271.
   PubMed Web of Science ®Google Scholar
• van der Waal I, de Bree R, Brakenhoff R, Coebergh JW. (2011). Early diagnosis in primary oral cancer: is it possible? Med Oral Patol Oral Cir Bucal 16:e300–e305
   PubMed Web of Science ®Google Scholar
• Verstappen J, Von den Hoff JW. (2006). Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease. J Dent Res 85:1074–1084.
   PubMed Web of Science ®Google Scholar
• Wakefield LM, Roberts AB. (2002). TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12:22–29.
   PubMed Web of Science ®Google Scholar
• Yang L. (2010). TGFbeta and cancer metastasis: an inflammation link. Cancer Metastasis Rev 29:263–271.
   Google Scholar
• Yang L, Moses HL. (2008). Transforming growth factor beta: tumour suppressor or promoter? Are host immune cells the answer? Cancer Res 68:9107–9111.
   PubMed Web of Science ®Google Scholar